ORAGENICS, INC. Payments to Acquire Businesses, Gross
ORAGENICS, INC. (OGEN) reported Payments to Acquire Businesses, Gross of $1.93 million for the 12-month period ending 2021-12-31, per its 10-K/A filed 2022-07-29.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesGross · last filed 2022-07-29
- ORAGENICS, INC. payments to acquire businesses, gross for the quarter ending 2021-06-30 was $0.00.
- ORAGENICS, INC. payments to acquire businesses, gross for the quarter ending 2021-03-31 was $1.93M.
- ORAGENICS, INC. payments to acquire businesses, gross for the quarter ending 2020-12-31 was $0.00.
- ORAGENICS, INC. payments to acquire businesses, gross for the quarter ending 2020-09-30 was $0.00.
- ORAGENICS, INC. payments to acquire businesses, gross for fiscal 2021 was $1.93M, a 0.00% change from fiscal 2020.
- ORAGENICS, INC. payments to acquire businesses, gross for fiscal 2020 was $1.93M.
| Period end | Payments to Acquire Businesses, Gross 3 month | Payments to Acquire Businesses, Gross 6 month | Payments to Acquire Businesses, Gross 9 month | Payments to Acquire Businesses, Gross 12 month |
|---|---|---|---|---|
| 2021-12-31 | $1.93M 10-K/A · filed 2022-07-29 | |||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $1.93M 10-Q · filed 2021-08-16 | $1.93M derived: sum of 3 quarters · filed 2021-08-16 | $1.93M derived: sum of 4 quarters · filed 2021-08-16 |
| 2021-03-31 | $1.93M 10-Q · filed 2021-05-03 | $1.93M derived: sum of 2 quarters · filed 2021-05-03 | $1.93M derived: sum of 3 quarters · filed 2021-05-03 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $1.93M 10-K · filed 2021-03-01 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $1.93M 10-Q · filed 2020-11-10 | ||
| 2020-06-30 | $1.93M 10-Q · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |